NCT02781883Phase 2Recruiting

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

Study sponsor: Bio-Path Holdings, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-12Estimated
Enrollment · participants108Estimated
Source updated2025-03-07Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview